EP4376834A4 - NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE - Google Patents

NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE

Info

Publication number
EP4376834A4
EP4376834A4 EP22850031.0A EP22850031A EP4376834A4 EP 4376834 A4 EP4376834 A4 EP 4376834A4 EP 22850031 A EP22850031 A EP 22850031A EP 4376834 A4 EP4376834 A4 EP 4376834A4
Authority
EP
European Patent Office
Prior art keywords
spiropyrrolidine
antiviral agents
agents derived
new antiviral
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22850031.0A
Other languages
German (de)
French (fr)
Other versions
EP4376834A1 (en
Inventor
Ruichao Shen
Yong He
Xuechao Xing
Matthew C. RHODES
Joseph D. PANARESE
Samuel Bartlett
Wei Li
Hui Cao
Jiajun Zhang
Xiaowen Peng
Guoqiang Wang
Yat Sun Or
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Enanta Pharmaceuticals Inc
Original Assignee
Enanta Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/479,248 external-priority patent/US11325916B1/en
Application filed by Enanta Pharmaceuticals Inc filed Critical Enanta Pharmaceuticals Inc
Publication of EP4376834A1 publication Critical patent/EP4376834A1/en
Publication of EP4376834A4 publication Critical patent/EP4376834A4/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/20—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP22850031.0A 2021-07-29 2022-04-14 NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE Pending EP4376834A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US202163227206P 2021-07-29 2021-07-29
US17/479,248 US11325916B1 (en) 2021-07-29 2021-09-20 Spiropyrrolidine derived antiviral agents
US202263324367P 2022-03-28 2022-03-28
PCT/US2022/024772 WO2023009187A1 (en) 2021-07-29 2022-04-14 Novel spiropyrrolidine derived antiviral agents

Publications (2)

Publication Number Publication Date
EP4376834A1 EP4376834A1 (en) 2024-06-05
EP4376834A4 true EP4376834A4 (en) 2025-06-18

Family

ID=85087186

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22850031.0A Pending EP4376834A4 (en) 2021-07-29 2022-04-14 NEW ANTIVIRAL AGENTS DERIVED FROM SPIROPYRROLIDINE

Country Status (8)

Country Link
EP (1) EP4376834A4 (en)
JP (1) JP2024529476A (en)
KR (1) KR20240044452A (en)
AU (1) AU2022319598A1 (en)
CA (1) CA3173702A1 (en)
IL (1) IL310246A (en)
MX (1) MX2024001377A (en)
WO (1) WO2023009187A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7559223B2 (en) 2020-08-24 2024-10-01 ギリアード サイエンシーズ， インコーポレイテッド Phospholipid compounds and uses thereof
TWI925033B (en) 2020-10-16 2026-05-11 美商基利科學股份有限公司 Phospholipid compounds and uses thereof
WO2023283256A1 (en) 2021-07-09 2023-01-12 Aligos Therapeutics, Inc. Anti-viral compounds
AU2023303408A1 (en) 2022-07-06 2024-12-19 Aligos Therapeutics, Inc. Anti-viral compounds
EP4612156A1 (en) * 2022-11-02 2025-09-10 Aligos Therapeutics, Inc. Anti-viral compounds
CN119139307B (en) * 2023-12-29 2025-09-23 上海柯君医药科技有限公司 Use of spirocyclic compounds in the preparation of 3CLpro protease inhibitors or drugs
WO2025221657A1 (en) * 2024-04-15 2025-10-23 Aligos Therapeutics, Inc. Anti-viral compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023086400A1 (en) * 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
WO2023125825A1 (en) * 2021-12-29 2023-07-06 Shanghai Curegene Pharmaceutical Co., Ltd. Anticoronviral compounds and compositions and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006061714A2 (en) * 2004-12-09 2006-06-15 Pfizer Inc. Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis
US8222288B2 (en) * 2006-08-30 2012-07-17 The Regents Of The University Of Michigan Small molecule inhibitors of MDM2 and the uses thereof
CA2661354C (en) * 2006-08-30 2012-12-18 The Regents Of The University Of Michigan New small molecule inhibitors of mdm2 and the uses thereof
US8575208B2 (en) * 2007-02-27 2013-11-05 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
UY37381A (en) * 2016-08-30 2018-03-23 Glaxosmithkline Ip No 2 Ltd COMPOUNDS THAT INHIBIT PROTEASES 3C AND 3CL AND METHODS OF USE OF THE SAME
US12398147B2 (en) * 2021-05-11 2025-08-26 Enanta Pharmaceuticals, Inc. Macrocyclic spiropyrrolidine derived antiviral agents
US11325916B1 (en) * 2021-07-29 2022-05-10 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023086400A1 (en) * 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
WO2023125825A1 (en) * 2021-12-29 2023-07-06 Shanghai Curegene Pharmaceutical Co., Ltd. Anticoronviral compounds and compositions and uses thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2023009187A1 *

Also Published As

Publication number Publication date
KR20240044452A (en) 2024-04-04
WO2023009187A1 (en) 2023-02-02
AU2022319598A1 (en) 2024-02-08
EP4376834A1 (en) 2024-06-05
CA3173702A1 (en) 2023-01-29
IL310246A (en) 2024-03-01
JP2024529476A (en) 2024-08-06
MX2024001377A (en) 2024-03-08

Similar Documents

Publication Publication Date Title
IL307478A (en) Thionucleosides as antiviral agents
EP4366831A4 (en) ANTIVIRAL COMPOUNDS
EP3911631A4 (en) NEW SUBSTITUTED SULFONYLUREA DERIVATIVES
PL4106876T3 (en) ANTIVIRAL COMPOUNDS
EP4504707A4 (en) ANTIVIRAL HETEROCYCLEAN COMPOUNDS
EP4159839A4 (en) ANTIVIRAL AGENT
EP4308577C0 (en) NEW THIADIAZOLOPYRIMIDONE DERIVATIVES
EP4232456A4 (en) ANTIVIRAL PRODRUG COMPOUNDS
EP4262816A4 (en) SYNTHESIS OF ANTIVIRAL NUCLEOSIDES
MA56504A (en) PYRIDIN-3-YLE DERIVATIVES
EP4151230A4 (en) ANTIVIRAL AGENT
ES1257355Y (en) COMPARTMENT MASK
JP1755966S (en) outerwear
ES1297425Y (en) Multipurpose telecommunications booth
JP1785322S (en) Sportswear
ES1285961Y (en) sportswear
IT202300013152A1 (en) THIAZOLIDINONES AS ANTIVIRAL AGENTS
TH2202002225S (en) bath
TH2102005652S (en) bath
UA44876S (en) BATH
TH2102004366S (en) bath
TH2102004367S (en) bath
JP1770848S (en) bicycle
JP1764238S (en) bicycle
JP1764237S (en) bicycle

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20240119

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40111114

Country of ref document: HK

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61K0031404000

Ipc: C07D0487100000

A4 Supplementary search report drawn up and despatched

Effective date: 20250516

RIC1 Information provided on ipc code assigned before grant

Ipc: A61P 31/14 20060101ALI20250512BHEP

Ipc: A61K 31/404 20060101ALI20250512BHEP

Ipc: C07D 519/00 20060101ALI20250512BHEP

Ipc: C07D 487/20 20060101ALI20250512BHEP

Ipc: C07D 487/10 20060101AFI20250512BHEP

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: ENANTA PHARMACEUTICALS, INC.